Action VCKAU VICKERS VANTAGE CORP. I
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues Vickers Vantage Corp. I Nasdaq

Actions

VCKAU

KYG9440B1234

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc. and Vickers Vantage Corp. I Announce the Closing of their Previously Announced Business Combination
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics Inc. Debuts on Nasdaq Under Ticker 'SCLX'
Vickers Vantage Corp. I(NasdaqCM:VCKA) dropped from NASDAQ Composite Index
Scilex Holding Company completed the acquisition of Vickers Vantage Corp. I from Vickers Venture Fund VI L.P. and Vickers Venture Fund VI Pte Ltd, managed by Vickers Venture Partners, Shaolin Capital Management LLC, Hudson Bay Capital Management LP and others in a reverse merger transaction.
VICKERS VANTAGE CORP. I : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
VICKERS VANTAGE CORP. I Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Vickers Vantage Corp. I Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Scilex Holding Company a Sorrento Company and Vickers Vantage Corp. I Announce Effectiveness of Registration Statement on Form S-4, Date of Vickers Vantage Extraordinary General Meeting to Approve Proposed Business Combination
Vickers Vantage I : Merger Agreement - Form 8-K
VICKERS VANTAGE CORP. I : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)
VICKERS VANTAGE CORP. I : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
Scilex Holding Company, a Sorrento Company, Announces That the FDA Has Granted Fast Track Designation for SP-103 5.4%, Next Generation Triple Strength Formulation of ZTlido, For the Treatment of Acute Low Back Pain
Scilex Holding Company, a Sorrento Company, Announces Exclusive Product Distribution Agreement with CH Trading Group LLC to Expand Commercialization of ZTlido
Scilex Holding Company, a Sorrento Company, Announces Expanding Coverage to 30 Million Lives And Will Continue To Work To Access An Additional 20 Million Lives With One Of The Largest National Pharmacy Benefit Managers
VICKERS VANTAGE CORP. I Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Vickers Vantage Corp. I Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Sorrento Therapeutics Unit Scilex Plans to Acquire Ancora Medical
Vickers Vantage I : Announces Shareholder Approval of Extension of Deadline to Complete Business Combination – Form 8-K
Vickers Vantage I : Announces Shareholder Approval of Extension of Deadline to Complete Business Combination - Form 8-K
VICKERS VANTAGE CORP. I : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action VCKA
  4. Action VCKAU
  5. Actualités Vickers Vantage Corp. I
  6. Autres langues